Sunshine Biopharma has achieved its goal of expanding its portfolio to 60 generic prescription drugs in Canada by the end of the year by adding nine new generics.
Sunshine Biopharma Expands Its Generics Portfolio In Canada
The Firm Reported A 67% YoY Gross Revenue Increase In Q2 2024
After adding nine generics to its portfolio, Sunshine Biopharma prepares for more launches in the next year to strengthen its presence in Canada.
